NCT06617039View on ClinicalTrials.gov

The Impact of Low-Dose Esketamine Combined With Ciprofol on the Quality of Early Postoperative Recovery Among Elderly Patients Undergoing Painless Gastroscopy

NAActive, not recruitingINTERVENTIONAL
Enrollment

376

Participants

Timeline

Start Date

October 10, 2024

Primary Completion Date

July 15, 2025

Study Completion Date

July 15, 2025

Conditions
Quality of Postoperative Recovery
Interventions
DRUG

Remifentanil and ciprofol

R group will be started with remifentanil 0.5ug/kg and ciprofol 0.4 mg/kg.

DRUG

esketamine 0.3mg/kg and ciprofol

Anesthesia induction was initiated by esketamine 0.3mg/kg, followed by ciprofol 0.2-0.4mg/kg.

DRUG

esketamine 0.5mg/kg and ciprofol

Anesthesia induction was initiated by esketamine 0.5mg/kg, followed by ciprofol 0.2-0.4mg/kg.

DRUG

Ciprofol

Ciprofol group will be started with ciprofol 0.2-0.4 mg/kg.

Trial Locations (1)

225001

Subei People's Hospital of Jiangsu Province, Yangzhou

All Listed Sponsors
lead

Northern Jiangsu People's Hospital

OTHER

NCT06617039 - The Impact of Low-Dose Esketamine Combined With Ciprofol on the Quality of Early Postoperative Recovery Among Elderly Patients Undergoing Painless Gastroscopy | Biotech Hunter | Biotech Hunter